NIH-funded research NIH-funded research

Developing a mouse model to study antibiotic-resistant gonorrhea

Official title: Task A100: Mouse Model of Neisseria Gonorrhoeae Antibiotic Resistant Infection

Funded at Pharmacology Discovery Services Taiwan, LTD. · NIH-11178799 · Data updated 2026-11-12

This study is working on developing better mouse models to understand gonorrhea infections, especially those that don't respond to antibiotics, so that we can find new treatments that could help people dealing with this tough health issue.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPharmacology Discovery Services Taiwan, LTD.
NIH-funded
Lab location1 site (New Taipei City, Taiwan)
Project startJuly 12, 2024
Project endJuly 11, 2025
Funding year2024
Award (this year)$331,260
NIH project number272201700020I-0-759302400002-1
Project IDNIH-11178799 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been diagnosed with gonorrhea, particularly those with antibiotic-resistant strains.

Less likely to help

Patients who do not have gonorrhea or those with non-resistant strains may not benefit from this research.

What this research studies

This research focuses on creating and improving mouse models to better understand infections caused by Neisseria gonorrhoeae, particularly those that are resistant to antibiotics. By simulating these infections in mice, researchers aim to evaluate potential treatments and countermeasures against this growing public health threat. Patients may benefit from insights gained through this research, which could lead to more effective therapies for antibiotic-resistant gonorrhea.

Why it matters

Potential benefit: If successful, this research could lead to the development of new treatments for antibiotic-resistant gonorrhea, improving patient outcomes.

How similar studies have gone: Previous research has shown success in developing animal models for studying antibiotic resistance, indicating that this approach has potential.

Where this research is happening

  • Pharmacology Discovery Services Taiwan, LTD.
    New Taipei City, Taiwan
    Active

Researchers

  • Principal investigator: Miesel, Lynn — Pharmacology Discovery Services Taiwan, LTD.
  • Study coordinator: Miesel, Lynn

Related research

Other NIH-funded projects on the same topics.

  • Developing models to study urinary tract infections caused by antibiotic-resistant bacteria

    This study is working on better ways to understand and treat urinary tract infections caused by antibiotic-resistant bacteria, which could help patients facing these tough infections in the future.

    NIH research Pharmacology Discovery Services Taiwan, LTD. · New Taipei City, Taiwan · NIH-11250927

  • Developing models to understand infectious diseases.

    This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.

    NIH research Pharmacology Discovery Services Taiwan, LTD. · New Taipei City, Taiwan · NIH-11197700

  • Testing new treatments for antibiotic-resistant bacterial infections in mice.

    This study is looking at how to better understand and treat infections caused by antibiotic-resistant bacteria using mice, which could help develop new treatments for patients who struggle with these tough infections.

    NIH research Pharmacology Discovery Services Taiwan, LTD. · New Taipei City, Taiwan · NIH-11178798

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.